Keyphrases
Duchenne muscular Dystrophy
100%
Ultrasound
27%
Quantitative Ultrasound
23%
Spinal muscular Atrophy
21%
Nerve
19%
Electrical Impedance Myography
19%
Onasemnogene Abeparvovec
16%
Backscatter
15%
Neuromuscular Disease
15%
Young children
14%
Gene Therapy
13%
Phase II Trial
13%
Backscatter Analysis
13%
Ultrasound Examination
12%
Dystrophin
12%
Intraclass Correlation Coefficient
11%
Skeletal muscle
11%
Quantitative muscle Ultrasound
11%
Grayscale Level
10%
Nerve Ultrasound
10%
Corticosteroids
10%
Non-ambulatory
10%
Randomized Double-blind
10%
SMN2
9%
Delandistrogene Moxeparvovec
9%
Viltolarsen
9%
Becker muscular Dystrophy
9%
Givinostat
9%
Placebo-controlled
9%
Muscle Thickness
9%
Muscular Dystrophy
9%
Disease Progression
9%
Myopathy
8%
Muscle Ultrasound
8%
Nerve Enlargement
8%
Clinical Trials
8%
Spinal muscular Atrophy Type 1
8%
Electrodiagnosis
8%
Chronic Inflammatory Demyelinating Polyneuropathy
7%
PYROXD1
6%
Non-ambulatory Patients
6%
Phenotypic Spectrum
6%
Nerve Transfer
6%
Polyneuropathy
6%
Connective Tissue
6%
Amyotrophic Lateral Sclerosis
6%
Blood Flow
6%
Myasthenia Gravis
6%
Critically Ill children
6%
Infantile Onset
6%
Medicine and Dentistry
Duchenne Muscular Dystrophy
91%
Myography
19%
Ultrasonography of Muscle
18%
Skeletal Muscle
16%
Dystrophin
14%
Spinal Muscular Atrophy
13%
Onasemnogene Abeparvovec
13%
Gene Therapy
13%
Myopathy
11%
Muscle Disease
11%
Adverse Event
10%
Disease
10%
Viltolarsen
9%
Becker Muscular Dystrophy
9%
Givinostat
9%
Placebo
9%
Arm
9%
Upper Limb
9%
Limb
9%
Neuromuscular Disease
9%
Disease Exacerbation
8%
Echography
8%
Electrodiagnosis
8%
Clinical Trial
8%
Werdnig Hoffmann Disease
8%
Exon
8%
Magnetic Resonance Imaging
7%
Injury
7%
Combination Therapy
6%
Nerve Transplantation
6%
Chronic Inflammatory Demyelinating Polyneuropathy
6%
Blood Flow
6%
Bayley Scales of Infant Development
6%
Pediatrics
6%
Median Nerve
5%
Diagnosis
5%
Spinal Cord Injury
5%
Peripheral Nerve
5%
Neuropathy
5%
Muscular Dystrophy
5%